Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The team of Francesca Finotello (Computational ...
May 24, 2024
0
6
Epigenetically active drugs enable the cell to read parts oft he genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as scientists from the German ...
Oct 24, 2023
0
40
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Feb 24, 2024
0
1
A team of University of Maryland researchers has made new strides in the fight against metastatic cancer by successfully combining three cutting-edge photoimmunotherapy technologies to help prevent the spread and return of ...
Oct 25, 2023
0
4
Scientists have discovered that some cancer cells pretend to be "super fit" to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body.
Jul 24, 2024
0
63
In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy ...
Jun 6, 2024
0
83
Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical ...
Apr 25, 2024
0
47
Researchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunotherapy treatments, such as CAR T-cell therapy, against solid tumors. T cells are specialized ...
Nov 1, 2023
0
4
Through innovative exploratory work, scientists have identified a new way to study proteins that are involved in the development of the majority of breast cancers.
Feb 13, 2024
0
22
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumor-suppressing gene called VHL, the first step in a huge research endeavor to unpick the outcomes of tens of thousands of ...
Jul 5, 2024
0
26
